Corona Remedies P/E Ratio

Current P/E Ratio
63.82
High Valuation
Very High - High growth expectations or significantly overvalued

Corona Remedies P/E ratio. Corona Remedies (CORONA) P/E ratio is 63.82 (High), EPS (TTM) ₹30.27, current price ₹2034.20 on NSE vs historical average P/E of 51.35 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Corona Remedies stock price NSE.

Current Valuation Metrics

P/E Ratio 63.82
Current Price ₹2034.20
EPS (TTM) ₹30.27
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 51.35
Historical Range 51.35 - 51.35
Percentile 100.0%

Sector Context

Sector Average 56.28
Sector Median 31.61
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹30.95
Mar 2026 ₹7.41
Jun 2026 ₹9.83

CORONA P/E Ratio — Valuation Signal & Historical Context

Corona Remedies P/E 63.82 vs historical average 51.35, range 51.35–51.35 — signal: Overvalued. Examine CORONA quarterly performance for recent quarterly revenue, profit and EPS trends.

  • Stock appears overvalued with PE of 63.82, suggesting caution for new investments
  • Current PE is 24.3% above historical average
  • Trading at premium to sector average PE of 56.28

Corona Remedies P/E Ratio Historical Trend

CORONA annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 63.82 vs historical average 51.35. Also explore Corona Remedies stock price data download to track price trends across different timeframes.

CORONA Historical P/E Ratio — EPS, Year-End Price & Valuation

Corona Remedies annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 51.35 28.01 ₹1438.40 NSE High

CORONA vs Healthcare Peers — P/E Ratio Comparison

Corona Remedies P/E 63.82 vs Healthcare average 56.28, median 31.61 — range 2.04–740.29.

Sector Average
56.28
Sector Median
31.61
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 4.29 ₹6,582 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
GKB Ophthalmics GKB 6.27 ₹33 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low